News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,912 Results
Type
Article (14549)
Company Profile (102)
Press Release (285261)
Section
Business (97687)
Career Advice (475)
Deals (17480)
Drug Delivery (67)
Drug Development (40041)
Employer Resources (49)
FDA (7096)
Job Trends (6579)
News (166649)
Policy (15501)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (513)
Accelerated approval (2)
Adcomms (6)
Allergies (35)
Alliances (26716)
ALS (39)
Alzheimer's disease (454)
Antibody-drug conjugate (ADC) (43)
Approvals (7138)
Artificial intelligence (109)
Autoimmune disease (8)
Automation (3)
Bankruptcy (151)
Best Places to Work (4686)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (42)
Bladder cancer (22)
Brain cancer (17)
Breast cancer (85)
Cancer (689)
Cardiovascular disease (73)
Career advice (416)
Career pathing (11)
CAR-T (23)
Cell therapy (103)
Cervical cancer (4)
Clinical research (33736)
Collaboration (364)
Compensation (142)
Complete response letters (17)
COVID-19 (863)
CRISPR (19)
C-suite (122)
Cystic fibrosis (39)
Data (703)
Denatured (15)
Depression (10)
Diabetes (86)
Diagnostics (1791)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (58)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (43)
Earnings (35802)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (41523)
Executive appointments (373)
FDA (7563)
Featured Employer (20)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (239)
Gene editing (39)
Generative AI (8)
Gene therapy (114)
GLP-1 (353)
Government (1416)
Grass and pollen (3)
Guidances (17)
Healthcare (4257)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (899)
Inflammatory bowel disease (60)
Inflation Reduction Act (6)
Influenza (16)
Intellectual property (50)
Interviews (59)
IPO (6765)
IRA (29)
Job creations (2133)
Job search strategy (382)
Kidney cancer (6)
Labor market (10)
Layoffs (179)
Leadership (3)
Legal (3785)
Liver cancer (30)
Lung cancer (96)
Lymphoma (57)
Machine learning (1)
Management (16)
Manufacturing (159)
MASH (33)
Medical device (2266)
Medtech (2269)
Mergers & acquisitions (10946)
Metabolic disorders (267)
Multiple sclerosis (25)
NASH (14)
Neurodegenerative disease (27)
Neuropsychiatric disorders (6)
Neuroscience (646)
NextGen: Class of 2025 (1721)
Non-profit (656)
Northern California (770)
Now hiring (7)
Obesity (150)
Opinion (119)
Ovarian cancer (21)
Pain (51)
Pancreatic cancer (19)
Parkinson's disease (47)
Partnered (7)
Patents (108)
Patient recruitment (33)
Peanut (10)
People (30841)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8958)
Phase II (14384)
Phase III (12593)
Pipeline (475)
Podcasts (46)
Policy (60)
Postmarket research (1449)
Preclinical (3574)
Press Release (27)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (133)
Rare diseases (167)
Real estate (2924)
Recruiting (17)
Regulatory (11163)
Reports (16)
Research institute (634)
Resumes & cover letters (56)
Rett syndrome (1)
RNA editing (2)
RSV (7)
Schizophrenia (37)
Series A (41)
Series B (14)
Service/supplier (4)
Sickle cell disease (31)
Southern California (782)
Special edition (6)
Spinal muscular atrophy (79)
Sponsored (6)
Startups (1853)
State (2)
Stomach cancer (4)
Supply chain (28)
The Weekly (29)
United States (7605)
Vaccines (166)
Venture capitalists (13)
Webinars (10)
Weight loss (95)
Women's health (9)
Worklife (3)
Date
Today (54)
Last 7 days (292)
Last 30 days (1106)
Last 365 days (13639)
2025 (3437)
2024 (14180)
2023 (16236)
2022 (22887)
2021 (23451)
2020 (22022)
2019 (16794)
2018 (13113)
2017 (15489)
2016 (14675)
2015 (17286)
2014 (13960)
2013 (11979)
2012 (12879)
2011 (13382)
2010 (12146)
Location
Africa (338)
Alabama (14)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (30896)
Australia (3999)
California (1848)
Canada (966)
China (292)
Colorado (66)
Connecticut (72)
Delaware (55)
Europe (45595)
Florida (311)
Georgia (38)
Idaho (9)
Illinois (192)
India (18)
Indiana (129)
Iowa (1)
Japan (114)
Kansas (59)
Kentucky (12)
Louisiana (1)
Maine (5)
Maryland (302)
Massachusetts (1551)
Michigan (31)
Minnesota (112)
Missouri (29)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (803)
New Mexico (7)
New York (566)
North Carolina (409)
North Dakota (3)
Northern California (770)
Ohio (51)
Oklahoma (5)
Oregon (17)
Pennsylvania (445)
Puerto Rico (8)
Rhode Island (7)
South America (552)
South Carolina (2)
Southern California (782)
Tennessee (34)
Texas (241)
Utah (44)
Virginia (70)
Washington D.C. (30)
Washington State (118)
Wisconsin (15)
299,912 Results for "beacon pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
Beacon Biosignals announced a strategic partnership with Longboard Pharmaceuticals, Inc. that combines Longboard’s drug development expertise with Beacon’s neurophysiological platform to develop a better understanding of the relationship between sleep and neurological conditions with an initial focus in rare epileptic syndromes.
May 13, 2024
·
2 min read
Press Releases
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 7, 2025
·
3 min read
Press Releases
Beacon Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for laru-zova (AGTC-501)
January 28, 2025
·
4 min read
Press Releases
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
January 9, 2025
·
13 min read
Press Releases
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
March 21, 2025
·
7 min read
Press Releases
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 14, 2025
·
4 min read
Genetown
Beacon Therapeutics Treats First Patient in VISTA Registrational Trial for AGTC-501
Beacon Therapeutics Holdings Limited, a leading ophthalmic gene therapy company with a mission to save and restore the vision of patients with blinding retinal diseases, announced the treatment of the first patient in its registrational VISTA clinical trial with its lead asset, AGTC-501.
June 12, 2024
·
3 min read
Press Releases
Beacon Biosignals Reports Novel Sleep EEG Results from Multiple Industry Collaborations at the American Epilepsy Society Annual Meeting
December 12, 2024
·
4 min read
Press Releases
Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025
January 6, 2025
·
4 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
1 of 29,992
Next
